Skip to content

Clinical trials

Phase 2 Neuralgia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuralgia Phase: Phase 2 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20092
20101
20121
20141
20171
20182
20192
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated5
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
AstraZeneca2
Novartis Pharmaceuticals2
Astellas Pharma Europe B.V.1
Aziende Chimiche Riunite Angelini Francesco S.p.A1
Bayer1
Grünenthal GmbH1
Lateral Pharma Pty Ltd1
Newron Pharmaceuticals SPA1
University of Edinburgh1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuralgia16
Neuralgia, Postherpetic4
Pain3
Chronic Pain2
Diabetes Mellitus2
Diabetic Neuropathies2
Peripheral Nervous System Diseases2
Back Pain1
Hypesthesia1
Kidney Diseases1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.